{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:26:48Z","timestamp":1774466808756,"version":"3.50.1"},"reference-count":38,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12714","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T12:22:15Z","timestamp":1726057335000},"source":"Crossref","is-referenced-by-count":1,"title":["Imatinib\u2011induced gynecomastia: A case report"],"prefix":"10.3892","volume":"28","author":[{"given":"Xiao-Lan","family":"Li","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Ke","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Jie","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Wei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Zhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Jishou University, Jishou, Hunan 416000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"key20240927091429_b1-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7150\/ijbs.86305","article-title":"Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"20","author":"Sun","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"e21077","key":"key20240927091429_b2-ETM-28-5-12714","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21077","article-title":"The progression of chronic myeloid leukemia to myeloid sarcoma: A systematic review","volume":"14","author":"Arzoun","year":"2022","journal-title":"Cureus"},{"key":"key20240927091429_b3-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11899-018-0474-6","article-title":"Chronic myeloid leukemia: Beyond BCR-ABL1","volume":"13","author":"Zhou","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"key20240927091429_b4-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ajh.24275","article-title":"Chronic myeloid leukemia: 2016 Update on diagnosis, therapy, and monitoring","volume":"91","author":"Jabbour","year":"2016","journal-title":"Am J Hematol"},{"key":"key20240927091429_b5-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1586\/14737140.2016.1151356","article-title":"Imatinib mesylate in chronic myeloid leukemia: Frontline treatment and long-term outcomes","volume":"16","author":"Stagno","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"key":"key20240927091429_b6-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"key20240927091429_b7-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.4103\/0973-1482.146095","article-title":"Newly diagnosed breast cancer in a patient receiving imatinib mesylate","volume":"10","author":"Kaygusuz-Atagunduz","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"key20240927091429_b8-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s12282-017-0786-8","article-title":"Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy","volume":"24","author":"Pan","year":"2017","journal-title":"Breast Cancer"},{"key":"key20240927091429_b9-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1078155211424629","article-title":"Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: A literature review","volume":"18","author":"Tanriverdi","year":"2012","journal-title":"J Oncol Pharm Pract"},{"key":"key20240927091429_b10-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3892\/etm.2017.4756","article-title":"Turner syndrome caused by rare complex structural abnormalities involving chromosome X","volume":"14","author":"Li","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20240927091429_b11-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/jcp.50.6.521","article-title":"A panel of antibodies for the immunostaining of Bouin's fixed bone marrow trephine biopsies","volume":"50","author":"Gala","year":"1997","journal-title":"J Clin Pathol"},{"key":"key20240927091429_b12-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"EC25","DOI":"10.7860\/JCDR\/2017\/25173.9650","article-title":"Morphological changes in bone marrow post imatinib therapy in chronic phase CML: A follow up study on sequential bone marrow aspirates and Biopsies","volume":"11","author":"Narang","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"key20240927091429_b13-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3892\/ol.2017.7538","article-title":"A unique bone marrow lymphoma patient presenting with an isolated mass: A case report","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol Lett"},{"key":"key20240927091429_b14-ETM-28-5-12714","first-page":"411","article-title":"A complex translocation t(5;9;22) in philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia","volume":"26","author":"Al-Achkar","year":"2007","journal-title":"J Exp Clin Cancer Res"},{"key":"key20240927091429_b15-ETM-28-5-12714","author":"Shaffer"},{"key":"key20240927091429_b16-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10577-010-9138-7","article-title":"Centromere activity in dicentric small supernumerary marker chromosomes","volume":"18","author":"Ewers","year":"2010","journal-title":"Chromosome Res"},{"key":"key20240927091429_b17-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/etm.2015.2707","article-title":"Nilotinib rapidly reverses breakpoint cluster region-Abelson oncogene fusion gene and M244V mutations in a patient with chronic myelogenous leukemia: A case report","volume":"10","author":"Shen","year":"2015","journal-title":"Exp Ther Med"},{"key":"key20240927091429_b18-ETM-28-5-12714","first-page":"336","article-title":"Clinico-pathologic features of chronic myeloid leukemia and risk stratification according to Sokal score","volume":"16","author":"Syed","year":"2006","journal-title":"J Coll Physicians Surg Pak"},{"key":"key20240927091429_b19-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1872214811666170301124033","article-title":"Gynecomastia in infants, children, and adolescents","volume":"10","author":"Leung","year":"2017","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"key20240927091429_b20-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.suc.2022.06.003","article-title":"Management of gynecomastia and male benign diseases","volume":"102","author":"Karamchandani","year":"2022","journal-title":"Surg Clin North Am"},{"key":"key20240927091429_b21-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3892\/ijmm.2018.3590","article-title":"Antiproliferative effects of imatinib mesylate on ZR-75-1 and MDA-MB-231 cell lines via PDGFR-\u03b2, PDGF-BB, c-Kit and SCF expression","volume":"42","author":"Kadivar","year":"2018","journal-title":"Int J Mol Med"},{"key":"key20240927091429_b22-ETM-28-5-12714","author":"Ma"},{"issue":"648","key":"key20240927091429_b23-ETM-28-5-12714","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_566_19","article-title":"IM-induced gynecomastia","volume":"23","author":"Gupta","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"key20240927091429_b24-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3346\/jkms.2005.20.3.512","article-title":"Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor","volume":"20","author":"Kim","year":"2005","journal-title":"J Korean Med Sci"},{"issue":"116","key":"key20240927091429_b25-ETM-28-5-12714","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-11-116","article-title":"Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: A rare adverse event","volume":"11","author":"Liu","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"key20240927091429_b26-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12288-016-0762-z","article-title":"Unilateral gynaecomastia in a young man with chronic myeloid leukemia","volume":"33","author":"Jain","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"key20240927091429_b27-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/S0140-6736(03)13554-4","article-title":"Gynaecomastia in men with chronic myeloid leukaemia after imatinib","volume":"361","author":"Gambacorti-Passerini","year":"2003","journal-title":"Lancet"},{"key":"key20240927091429_b28-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4274\/TJH-2013-0109","article-title":"Gynecomastia in a boy with chronic myeloid leukemia during imatinib therapy","volume":"30","author":"Tavil","year":"2013","journal-title":"Turk J Haematol"},{"key":"key20240927091429_b29-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11596-011-0167-z","article-title":"Bilateral masculine mastoplasia associated with imatinib mesylate: A case report and literature review","volume":"31","author":"Zhao","year":"2011","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20240927091429_b30-ETM-28-5-12714","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0093-7754(01)90097-1","article-title":"The biology of signal transduction inhibition: Basic science to novel therapies","volume":"28 (5 Suppl 17)","author":"Griffin","year":"2001","journal-title":"Semin Oncol"},{"key":"key20240927091429_b31-ETM-28-5-12714","first-page":"599","article-title":"The role of stem cell factor and of alternative c-kit gene products in the establishment, maintenance and function of germ cells","volume":"44","author":"Sette","year":"2000","journal-title":"Int J Dev Biol"},{"key":"key20240927091429_b32-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1158\/0008-5472.CAN-04-2181","article-title":"Imatinib mesylate inhibits Leydig cell tumor growth: Evidence for in vitro and in vivo activity","volume":"65","author":"Basciani","year":"2005","journal-title":"Cancer Res"},{"key":"key20240927091429_b33-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1177\/1078155213500686","article-title":"Effect of imatinib on male reproductive hormones in BCR-ABL positive CML patients: A preliminary report","volume":"20","author":"Ghalaut","year":"2014","journal-title":"J Oncol Pharm Pract"},{"key":"key20240927091429_b34-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3760\/cma.j.issn.0253-2727.2013.09.006","article-title":"Effects of imatinib mesylate on the levels of endocrine hormones","volume":"34","author":"Hou","year":"2013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"key20240927091429_b35-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-91439-8_2","article-title":"Dasatinib","volume":"212","author":"Lindauer","year":"2018","journal-title":"Recent Results Cancer Res"},{"key":"key20240927091429_b36-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1038\/leu.2008.106","article-title":"Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia","volume":"22","author":"Caocci","year":"2008","journal-title":"Leukemia"},{"key":"key20240927091429_b37-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.bjps.2022.02.008","article-title":"Approach to gynecomastia and pseudogynecomastia surgical techniques and its outcome: A systematic review","volume":"75","author":"Prasetyono","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key20240927091429_b38-ETM-28-5-12714","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0090-4295(00)00823-2","article-title":"Gynecomastia in patients with prostate cancer: A review of treatment options","volume":"56","author":"McLeod","year":"2000","journal-title":"Urology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:14:39Z","timestamp":1727417679000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,11]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12714","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"article-number":"425"}}